Opus Genetics
Price & Volume
Stats
See moreOpen | $4.08 |
Previous Close | $3.93 |
Day Range | $4.04-$4.19 |
52W Range | $1.70-$7.07 |
Market Cap | $326.9M |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $9.8M |
Revenue Growth (YoY) | -73.8% |
Gross Profit (12 Mos) | -$28.7M |
Diluted EPS | -$1.35 |
News
See moreYahoo Finance • 14 days ago
Sector Update: Healthcare Stocks Decline Wednesday Afternoon
Yahoo Finance • 19 days ago
Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
Yahoo Finance • 2 months ago
Sector Update: Healthcare Stocks Softer Late Afternoon
Yahoo Finance • 4 months ago
RBC Capital Bullish On Opus Genetics (IRD) Amid Limited Competition And De-Risked Setup
About
CEO | Dr. George Magrath M.B.A., M.D., M.S. |
CFO | Mr. Robert E. Gagnon CPA, M.B.A. |
Address | 8 Davis Drive, Durham, NC, United States, 27713 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 27 |